Detalles de la búsqueda
1.
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.
Oncologist
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520742
2.
Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing.
Cytopathology
; 34(6): 519-529, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37640801
3.
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis.
Breast Cancer Res Treat
; 191(1): 137-145, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34609640
4.
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence.
Breast Cancer Res
; 21(1): 153, 2019 12 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31888717
5.
Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline.
Virchows Arch
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38532196
6.
Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary group.
Crit Rev Oncol Hematol
; 193: 104217, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38040072
7.
HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions.
Mod Pathol
; 26(6): 816-24, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23348899
8.
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards.
Cancers (Basel)
; 14(13)2022 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35804968
9.
Schwann cell hamartoma: case report.
BMC Gastroenterol
; 11: 68, 2011 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21663626
10.
Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study.
J Bras Pneumol
; 47(4): e20200584, 2021.
Artículo
en Inglés, Portugués
| MEDLINE | ID: mdl-34259745
11.
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations.
Breast
; 59: 94-101, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34217971
12.
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
Genes (Basel)
; 11(7)2020 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32605290
13.
Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study / Avaliação prospectiva de espécimes obtidos por meio de EBUS-TBNA quanto à expressão de programmed death-ligand 1 em pacientes com câncer pulmonar de células não pequenas: um estudo piloto
J. bras. pneumol
; 47(4): e20200584, 2021. tab, graf
Artículo
en Inglés
| LILACS | ID: biblio-1279298
14.
Digital Slides as an Effective Tool for Programmed Death Ligand 1 Combined Positive Score Assessment and Training: Lessons Learned from the "Programmed Death Ligand 1 Key Learning Program in Head-and-Neck Squamous Cell Carcinoma".
J Pathol Inform
; 12: 1, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34012705
15.
Contrast-enhanced computed tomography colonography in preoperative distinction between T1-T2 and T3-T4 staging of colon cancer.
Acad Radiol
; 20(5): 590-5, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23477825
16.
Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer.
Clin Lung Cancer
; 17(5): e179-e183, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27349506
Resultados
1 -
16
de 16
1
Próxima >
>>